BONSPRI is contraindicated in patients with: Active HBV infection [see Infections under Precautions]; History of hypersensitivity to ofatumumab or life-threatening injection-related reaction to BONSPRI. Hypersensitivity reactions have included anaphylaxis and angioedema [see Injection-Related Reactions and Hypersensitivity Reactions under Precautions].